Feb 5 (Reuters) - Europe's largest copper producer Aurubis reported first quarter operating core profit slightly below market expectations on Thursday, hit by lower treatment and refining charges for ...

One of the most enduring goals in regenerative medicine is deceptively simple: replace a person's damaged or dying cells with healthy new ones grown in the laboratory. Researchers at Harvard Medical ...

Under an agreement announced Monday, Feb. 23, Organon will pay $27.5 million upfront for the right to market Sebela’s Miudella, billed as the first FDA-approved device of its kind in 40 years.

CHANGSHA, HUNAN, CHINA, January 19, 2026 /EINPresswire.com/ — In the world of industrial metallurgy, companies that can combine technical precision with production ...

The research in this week’s report investigates new energy storage materials and processes and advanced nuclear and fusion power ...

One of the symptoms of Wilson's disease (hepatolenticular degeneration) is an increased output of copper in the urine. This now seems to be linked with a defect in the binding of copper to amino-acid ...